Carbiotix, an award winning pre-clinical stage therapeutics company leveraging low-cost gut health testing
and microbiome modulators to unlock the potential of the gut microbiome to address a range of chronic and
metabolic diseases, closes its latest funding round and takes aim at ramping up therapeutics development
Carbiotix, an award-winning personalized nutrition company focused on consumer gut health
solutions and microbiome therapeutics, has started a 600-person gut health study to be conducted
over four months. Using the company’s own StudyGut platform launched in October, the final
participants were selected and registered from over 3,800 applicants.
Carbiotix, an award winning biotechnology start-up focused on optimizing gut health with soluble fiber
(prebiotics), has closed a second pre-seed financing round of 450,000 Euros, bringing the total capital raised
to date to 700,000 Euros
Over 80% of adults in the developed world are not consuming enough fiber in their diet, increasing the
risk of developing health problems. Carbiotix based in Lund, Sweden, aims to fill this "fiber gap" by
launching the world’s first personalized fiber supplement for gut health.